Difference between revisions of "Regimen classes"
Jump to navigation
Jump to search
| Line 15: | Line 15: | ||
==Platinum doublet== | ==Platinum doublet== | ||
| + | =Single-agent regimen= | ||
| + | ==Single-agent chemotherapy== | ||
| + | ==Single-agent immunotherapy== | ||
=Trastuzumab-based regimen= | =Trastuzumab-based regimen= | ||
| + | |||
=Tyrosine kinase inhibitor therapy= | =Tyrosine kinase inhibitor therapy= | ||
==BRAF TKI therapy== | ==BRAF TKI therapy== | ||
Revision as of 17:45, 22 January 2020
The purpose of this page is to define regimen classes that will be used in the HemOnc vocabulary; it is not for other purposes at this time.